PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023
Reportstack, provider of premium market research reports announces the addition of PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023 market report to its offering
The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as...
View full press release